These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6385647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind trial of ticlopidine in sickle cell disease.
    Semple MJ, Al-Hasani SF, Kioy P, Savidge GF.
    Thromb Haemost; 1984 Jul 29; 51(3):303-6. PubMed ID: 6388012
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
    Tohgi H.
    Agents Actions Suppl; 1984 Jul 29; 15():279-82. PubMed ID: 6385652
    [No Abstract] [Full Text] [Related]

  • 6. Ticlopidine: quo vadis? Subarachnoid hemorrhage.
    Ono H, Mizukami M, Kitamura K, Kikuchi H.
    Agents Actions Suppl; 1984 Jul 29; 15():259-72. PubMed ID: 6385650
    [No Abstract] [Full Text] [Related]

  • 7. Ticlopidine and coronary surgery.
    Limet R, David JL, Rigo P.
    Agents Actions Suppl; 1984 Jul 29; 15():188-98. PubMed ID: 6385646
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of ticlopidine on peripheral obliterating arteriopathy].
    Stiegler H, Hess H, Mietaschk A, Trampisch HJ, Ingrisch H.
    Dtsch Med Wochenschr; 1984 Aug 17; 109(33):1240-3. PubMed ID: 6381015
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of oral drugs for intermittent claudication of the legs in phase III clinical trials. Options selected for the ACT study].
    Destors JM, Arcan JC.
    Therapie; 1985 Aug 17; 40(6):451-8. PubMed ID: 4089787
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW, Kennedy LD.
    Ann Pharmacother; 1997 Nov 17; 31(11):1393-6. PubMed ID: 9391697
    [Abstract] [Full Text] [Related]

  • 16. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
    Mirouze J.
    Agents Actions Suppl; 1984 Nov 17; 15():230-58. PubMed ID: 6385649
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Canadian American ticlopidine study (cats) in thromboembolic stroke.
    Gent M, Ellis D.
    Agents Actions Suppl; 1984 Nov 17; 15():283-96. PubMed ID: 6385653
    [Abstract] [Full Text] [Related]

  • 19. Registry of prospective clinical trials--fifth report.
    Verstraete M.
    Thromb Haemost; 1982 Dec 27; 48(3):334-8. PubMed ID: 6761891
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.